Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Eklund

Showing results (81-90 of 207) with videos related to

Pageof 21
Sort By:
Scandinavian Journal of Urology|December 27, 2019
Lower urinary tract symptoms (LUTS) are not associated with an increased risk of prostate cancer in men 50-69 years with PSA ≥3 ng/mlJan Chandra Engel, Thorgerdur Palsdottir, Markus Aly, et al.
European Urology Oncology|October 23, 2024
Diagnostic Effects of Omitting Systematic Biopsies in Prostate Cancer ScreeningJan Chandra Engel, Martin Eklund, Fredrik Jäderling, et al.
European Urology Open Science|May 2, 2022
A Head-to-head Comparison of Prostate Cancer Diagnostic Strategies Using the Stockholm3 Test, Magnetic Resonance Imaging, and Swedish National Guidelines: Results from a Prospective Population-based Screening StudyMauritz Waldén, Mattias Aldrimer, Jakob Heydorn Lagerlöf, et al.
JNCI Cancer Spectrum|July 31, 2019
The WISDOM Personalized Breast Cancer Screening Trial: Simulation Study to Assess Potential Bias and Analytic ApproachesMartin Eklund, Kristine Broglio, Christina Yau, et al.
Plos One|June 14, 2019
Are Prostate Specific-Antigen (PSA) and age associated with the risk of ISUP Grade 1 prostate cancer? Results from 72 996 individual biopsy cores in 6 083 men from the Stockholm3 studyThorgerdur Palsdottir, Tobias Nordström, Markus Aly, et al.
Acta Oncologica (Stockholm, Sweden)|May 21, 2015
Public interest in and acceptability of the prospect of risk-stratified screening for breast and prostate cancerMarie Koitsalu, Mirjam A G Sprangers, Martin Eklund, et al.
Journal of Chemical Information and Modeling|September 18, 2014
Ligand-based target prediction with signature fingerprintsJonathan Alvarsson, Martin Eklund, Ola Engkvist, et al.
European Urology Open Science|October 3, 2022
Digital Rectal Examination in Stockholm3 Biomarker-based Prostate Cancer ScreeningJoel Andersson, Thorgerdur Palsdottir, Anna Lantz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2015
Associations of Breast Cancer Risk Prediction Tools With Tumor Characteristics and MetastasisJohanna Holm, Jingmei Li, Hatef Darabi, et al.
The Lancet. Digital Health|December 17, 2020
Effect of artificial intelligence-based triaging of breast cancer screening mammograms on cancer detection and radiologist workload: a retrospective simulation studyKarin Dembrower, Erik Wåhlin, Yue Liu, et al.
Pageof 21

Showing results (81-90 of 207) with videos related to

Sort By:
Pageof 21
Scandinavian Journal of Urology|December 27, 2019
Lower urinary tract symptoms (LUTS) are not associated with an increased risk of prostate cancer in men 50-69 years with PSA ≥3 ng/mlJan Chandra Engel, Thorgerdur Palsdottir, Markus Aly, et al.
European Urology Oncology|October 23, 2024
Diagnostic Effects of Omitting Systematic Biopsies in Prostate Cancer ScreeningJan Chandra Engel, Martin Eklund, Fredrik Jäderling, et al.
European Urology Open Science|May 2, 2022
A Head-to-head Comparison of Prostate Cancer Diagnostic Strategies Using the Stockholm3 Test, Magnetic Resonance Imaging, and Swedish National Guidelines: Results from a Prospective Population-based Screening StudyMauritz Waldén, Mattias Aldrimer, Jakob Heydorn Lagerlöf, et al.
JNCI Cancer Spectrum|July 31, 2019
The WISDOM Personalized Breast Cancer Screening Trial: Simulation Study to Assess Potential Bias and Analytic ApproachesMartin Eklund, Kristine Broglio, Christina Yau, et al.
Plos One|June 14, 2019
Are Prostate Specific-Antigen (PSA) and age associated with the risk of ISUP Grade 1 prostate cancer? Results from 72 996 individual biopsy cores in 6 083 men from the Stockholm3 studyThorgerdur Palsdottir, Tobias Nordström, Markus Aly, et al.
Acta Oncologica (Stockholm, Sweden)|May 21, 2015
Public interest in and acceptability of the prospect of risk-stratified screening for breast and prostate cancerMarie Koitsalu, Mirjam A G Sprangers, Martin Eklund, et al.
Journal of Chemical Information and Modeling|September 18, 2014
Ligand-based target prediction with signature fingerprintsJonathan Alvarsson, Martin Eklund, Ola Engkvist, et al.
European Urology Open Science|October 3, 2022
Digital Rectal Examination in Stockholm3 Biomarker-based Prostate Cancer ScreeningJoel Andersson, Thorgerdur Palsdottir, Anna Lantz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2015
Associations of Breast Cancer Risk Prediction Tools With Tumor Characteristics and MetastasisJohanna Holm, Jingmei Li, Hatef Darabi, et al.
The Lancet. Digital Health|December 17, 2020
Effect of artificial intelligence-based triaging of breast cancer screening mammograms on cancer detection and radiologist workload: a retrospective simulation studyKarin Dembrower, Erik Wåhlin, Yue Liu, et al.
Pageof 21